Första AP-fonden’s 10x Genomics TXG Stock Holding History

Första AP-fonden’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,300	Closed	-$104K	–	618
2022 Q2	$104K	Sell	2,300 -16,600	-88%	-$861K	﹤0.01%	588
2022 Q1	$1.44M	Buy	+18,900	New	+$1.65M	0.02%	520
2021 Q1	–	Sell	-3,400	Closed	-$481K	–	555
2020 Q4	$481K	Buy	+3,400	New	+$493K	0.01%	507

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Första AP-fonden's TXG Position: Q3 2022 in Review

Första AP-fonden sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 2,300 shares — an estimated $104K sold.

Första AP-fonden first reported a position in TXG in Q4 2020 and held it in 3 quarters. The position peaked at $1.44M in Q1 2022. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

Första AP-fonden reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
Första AP-fonden sold 2,300 10x Genomics shares in Q3 2022, an estimated $104K.
Första AP-fonden first reported a position in 10x Genomics in Q4 2020 and held it in 3 quarters.
Första AP-fonden's 10x Genomics position peaked at $1.44M in Q1 2022.
233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on Första AP-fonden's 13F filing for Q3 2022, filed 17 Oct 2022.